Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Differential clinicopathological and molecular features within late-onset colorectal cancer according to tumor location

  • Brandariz, Lorena
  • Arriba, María
  • García, Juan Luis
  • Cano, Juana María
  • Rueda, Daniel
  • Rubio, Eduardo
  • Rodríguez, Yolanda
  • Pérez, Jessica
  • Vivas, Alfredo
  • Sánchez, Carmen
  • Tapial, Sandra
  • Pena, Laura
  • García-Arranz, Mariano
  • García-Olmo, Damián
  • Urioste, Miguel
  • González-Sarmiento, Rogelio
  • Perea, José
Background: Since there is a predilection of some clinical and molecular features for a given tumor location, we assessed whether this can be confirmed in late-onset colorectal cancer (LOCRC). Results: Right colon cancers showed features associated with sporadic Microsatellite Instability: predominance of female cases and BRAF mutations, and an important mucinous component. Left colon cancers developed a higher number of polyps and multiple primary CRCs, showed the strongest familial component, and had better prognosis. Rectal cancers showed a predominantly sporadic phenotype, with worse prognosis and a CpG Island Methylator Phenotype (CIMP)-High. No copy number alterations (CNAs) greater than or equal to 50% were observed in this LOCRC group, and the most recurrent alterations were losses at 5q13 and 14q11, and gains at 7q11, 7q21-q22, 19p13-p12, 19q13 and 20p11-q11. KRAS and PIK3CA were the only mutated genes showing differences according to the tumor location, mainly for right colon cancers. Materials and Methods: We analyzed clinical and molecular characteristics of LOCRC at different tumor locations in order to determine if there are differential phenotypes related with the location in the colon. Conclusions: Categorizing LOCRC according to tumor location appears to be an adequate first step to resolving the heterogeneity of this subset of CRC.
Repisalud
Publication Artículo científico (JournalArticle)

NOMO-1 gene is deleted in early-onset colorectal cancer

  • Perea, José
  • García, Juan Luis
  • Pérez, Jessica
  • Rueda, Daniel
  • Arriba, María
  • Rodríguez, Yolanda
  • Urioste, Miguel
  • González-Sarmiento, Rogelio
To characterize clinical features of a recurrent alteration in 16p13.12-p13.11 in Colorectal Cancer (CRC), mainly in Early-onset subgroup (EOCRC), and to assess the status of NOMO1, a gene located in that region, we analyzed differential clinicopathological, familial and molecular features of CRC subsets with and without alterations in the 16p13.12-p13.11, in global and EOCRC groups. We confirmed the region by fluorescence in-situ hybridization, and Quantitative Real-Time PCR analyzed the status of NOMO1 in different age-of-onset and Microsatellite Instability (MSI)-status CRC subsets. Both age-of-onset subsets were subsequently extended to further confirm NOMO1 gene changes. 16p13.12-p13.11 alterations were observed in 23.3% of CRCs, and was detected more frequently in EOCRC (33.3%) than in late-onset CRC (16.3%). The group with deletion in 16p showed a higher frequency of females and left-colon locations; a better prognosis; and higher Chromosomal Instability. Within the primary EOCRC population, 34 out of 34 of tumours showed a homozygous deletion in NOMO1, while in the late-onset population only 2 of the 17 tumours (11.7%) showed it. In the extended group, we found 61 out of 75 EOCRC patients (81.3%) with homozygous deletion and 7 patients (9.3%) with heterozygous deletion of NOMO1; moreover, in the new 50 late-onset patients, the proportions of deletions decreased. Microsatellite-Stable (MSS) EOCRC showed a very high proportion of homozygous loss of NOMO1 (54 of 59 cases, 91.5%), while the deletion was observed in only 7 out of 16 MSI cases. Deletion of NOMO1 is a molecular marker predominantly associated with EOCRC, particularly MSS subtypes.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Decreased number of myeloid-derived suppressor cells in the placental trophoblast of gestational diabetes mellitus. Possible role of leptin

  • Tami, Malika
  • Hontecillas-Prieto, Lourdes
  • García-Domínguez, Daniel
  • Flores-Campos, Rocío
  • Vilariño-García, Teresa
  • Sánchez-Jiménez, Flora
  • Guadix, Pilar
  • Dueñas, José L
  • Jiménez-Cortegana, Carlos
  • Cruz-Merino, Luis de la
  • Pérez-Pérez, Antonio
  • Sánchez-Margalet, Víctor
Gestational diabetes mellitus (GDM) is the most common complication of pregnancy and significantly increases both maternal and fetal morbidity and mortality. Inflammation is a hallmark of GDM, and placental inflammation may play a key role in the pathophysiology of the disease. Myeloid-derived suppressor cells (MDSCs), which are innate immunosuppressive, are thought to contribute to feto-maternal tolerance. In normal pregnancies, elevated levels of MDSCs have been observed in both peripheral and umbilical cord blood. Our hypothesis postulates that trophoblasts from placentas belonging to women with GDM may have lower levels of MDSCs compared to trophoblasts from placentas originating from healthy pregnancies. Furthermore, since leptin is overexpressed in the placenta of GDM patients, we hypothesized that leptin might contribute to the reduction of MDSCs. To test this, we investigated the in vitro effects of leptin on MDSC levels in isolated peripheral blood leukocytes after 24 h of incubation. Our findings indicate that trophoblasts from placentas from women with GDM contain a lower percentage of MDSCs compared to trophoblasts from healthy pregnancies. In addition, in vitro studies demonstrated that leptin reduces the number of MDSCs in peripheral blood leukocytes. In conclusion, MDSCs are decreased in placentas from pregnancies with GDM, and leptin appears to reduce the number of MDSCs in leukocytes isolated in vitro. Increased leptin expression in trophoblasts from placentas of women with GDM may contribute to the lower levels of MDSCs, potentially playing a role in placental inflammation. However, further investigations are required to fully elucidate this mechanism., This research was funded by a grant from Instituto de Salud Carlos III (ISCIII) (PI19/01741), funded in part by FEDER Funds to VS-M. L.H-P. is supported by Miguel Servet research fellow at Instituto de Salud Carlos III. D.J.G-D. is supported by the VII Plan Propio de Investigación y Transferencia of Universidad de Sevilla [Contrato de Acceso (II.4)/VII PPIT-US]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Research data Set de datos (Dataset)

Dataset del proyecto Papel de la leptina en el transporte placentario y su implicación en la diabetes gestacional (ISCIII PI19/01741)

  • Pérez-Pérez, Antonio
  • Sánchez-Margalet, Víctor
Datos de niveles de células MDSC en placentas controles y de diabetes gestacional. Datos de expresión de transportadores lipídicos en placentas controles y de diabetes gestacional., PI19/01741, Instituto de Salud Carlos III, Figuras y tablas de resultados del proyecto contenidas en parte en un artículo publicado y otras contenidas en un artículo en revisión., Peer reviewed
Docta Complutense
Publication Artículo científico (JournalArticle)

Experiences and mediating factors in nurses' responses to electronic device alarms: A phenomenological study

  • López Espuela, Fidel
  • Rodríguez Martin, Beatriz
  • Lavado García, Jesús
  • Toribio Felipe, Rosaura
  • Amarilla Donoso, Francisco Javier
  • Rodríguez Almagro, Julián Javier
  • Fernandes Ribeiro, Ana Sofía
  • Leite Fernandes, Vitor Samuel
  • Moran García, José María
Aim This study aims to explore the experiences and mediating factors of nurses' responses to electronic device alarms in critical care units (CCUs). Background Alarm fatigue occasionally has adverse consequences for patient safety. Methods This qualitative study was designed and analysed following Giorgi's descriptive phenomenological approach. Seventeen nurses were theoretically sampled, reaching information saturation. Semistructured interviews were used to collect the data. Results Three central themes explained nurses' experiences: general perceptions about alarms (basic equipment of the CCU), strategies to reduce false alarms (training in the configuration of monitors, customization of the alarms to fit he patient's condition. teamwork and taking advantage of the development of technology) and key elements of the response to alarms (information about patient's condition, nurses' clinical experience, type of CCU, ‘cry-wolf’ phenomenon and nurse/patient ratio). Conclusions To reduce false alarms, nurses need further postgraduate training, training on monitors and customizing alarms to fit the patient's health status. The complex process of deciding to respond to an alarm includes environmental, professional variables and patient status. Implications for Nursing Management Nurse managers should ensure that nurses have sufficient experience and training in the CCU, improve the nurse/patient ratio, promote teamwork and ensure that the devices are the latest generation.